EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis

Alper Coskun iD, Ahmet Bilgehan Sahin iD, Selva Kabul iD, Muhammed Abdurrahman Celik, Mursel Sali iD, Ender Eren Ozcelik iD, Adem Deligonul iD, Erdem Cubukcu, Meral Kurt iD, Gursel Savci, Turkkan Evrensel, Ismet Yavascaoğlu

Current Oncology · 2025

DOI: 10.3390/curroncol32070394 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Current Oncology, 2025. Verfasst von Alper Coskun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Uludag University Faculty of Medicine, Bursa 16059, Turkey. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Carcinoma, Squamous Cell. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective: Bladder cancer (BC) is the ninth most common malignancy worldwide. Squamous cell carcinoma (SqCC), a rare histological variant, accounts for approximately 2–5% of all BC cases. Compared to urothelial carcinoma, the predominant subtype, research on SqCC remains limited and shows inconsistent findings regarding prognosis. This study aimed to compare survival outcomes between patients with SqCC and those with pure urothelial carcinoma (PUC).

Methods

This retrospective, observational study analyzed pathology reports from 2549 transurethral resections of bladder tumors and 632 cystectomies performed at our institution between 1 December 2010 and 31 December 2023. Following pathological re-evaluation, 33 patients with SqCC and 132 with PUC were identified. After 1:3 propensity score matching, 20 patients with SqCC and 58 with PUC were included in the final analysis. Demographic, clinicopathological features, and survival outcomes were compared between groups.

Results

The median follow-up was 2.31 years (range: 0.17–13.50). No significant differences in baseline demographic or clinical characteristics were observed, except for the type of surgery. Kaplan–Meier analysis demonstrated no significant differences in disease-free survival (DFS; p = 0.961) or overall survival (OS; p = 0.847) between SqCC and PUC groups. Multivariate Cox regression analysis identified T stage, nodal involvement, and adjuvant chemotherapy (CT) as independent predictors of DFS, while sex and metastasis at diagnosis were significant predictors of OS.

Conclusion

Survival outcomes (DFS and OS) did not significantly differ between patients with SqCC and patients with PUC. Prognosis was more closely associated with disease stage at diagnosis, sex, and adjuvant CT. Further large-scale studies are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCarcinoma, Squamous CellHumansMaleFemalePropensity ScoreAgedRetrospective StudiesMiddle AgedAged, 80 and overPrognosisAdult

Stichwörter der Autor:innen

bladdercancerpropensity score matchingsquamous cell carcinomasurvival

Autor:innen und Institutionen

  • Department of Medical Oncology, Uludag University Faculty of Medicine, Bursa 16059, Turkey.
  • Department of Pathology, Uludag University Faculty of Medicine, Bursa 16059, Turkey.
  • Department of Internal Medicine, Uludag University Faculty of Medicine, Bursa 16059, Turkey.
  • Department of Radiation Oncology, Uludag University Faculty of Medicine, Bursa 16059, Turkey.
  • Department of Radiology, Uludag University Faculty of Medicine, Bursa 16059, Turkey.
  • Department of Urology, Uludag University Faculty of Medicine, Bursa 16059, Turkey.

ORCID-Profile: Alper Coskun, Ahmet Bilgehan Sahin, Selva Kabul, Mursel Sali, Ender Eren Ozcelik, Adem Deligonul, Meral Kurt

Zitieren

APA

Coskun, A., Sahin, A. B., Kabul, S., Celik, M. A., Sali, M., Ozcelik, E. E., Deligonul, A., Cubukcu, E., Kurt, M., Savci, G., Evrensel, T., & Yavascaoğlu, I. (2025). Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis. Current Oncology. https://doi.org/10.3390/curroncol32070394

Vancouver

Coskun A, Sahin AB, Kabul S, Celik MA, Sali M, Ozcelik EE, et al. Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis. Current Oncology. 2025. doi:10.3390/curroncol32070394

BibTeX
@article{Coskun2025,
  author = {Coskun, Alper and Sahin, Ahmet Bilgehan and Kabul, Selva and Celik, Muhammed Abdurrahman and Sali, Mursel and Ozcelik, Ender Eren and Deligonul, Adem and Cubukcu, Erdem and Kurt, Meral and Savci, Gursel and Evrensel, Turkkan and Yavascaoğlu, Ismet},
  title = {Survival Outcomes in Patients with Squamous Cell Carcinoma of the Urinary Bladder: A Propensity Score-Matched Analysis},
  journal = {Current Oncology},
  year = {2025},
  doi = {10.3390/curroncol32070394}
}
Kostenlos starten →